Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immediate vs Deferred Chemotherapy After Radical Cystectomy for Bladder Cancer
NCT00028756Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 2001
- Primary completion
- Jan 2014
- Modality
- Targeted Liposomes, Orthosteric Ligands, Stealth (PEGylated) Liposomes
01
Overview
A Phase 3 trial of methotrexate, vinblastine, pegylated liposomal doxorubicin, Cisplatin micelle injection (HA132), gemcitabine in bladder cancer, sponsored by European Organisation for Research and Treatment of Cancer. Started Oct 2001; status: completed.
02
Drugs
methotrexatevinblastinepegylated liposomal doxorubicinCisplatin micelle injection (HA132)gemcitabine
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00028756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028756.